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Abstract 
The mechanisms responsible for painful and insensate diabetic neuropathy are not 
completely understood.  Here, we have investigated sensory neuropathy in the Ins2+/Akita 
mouse, a hereditary model of diabetes.  Akita mice become diabetic soon after weaning, 
and we show that this is accompanied by an impaired mechanical and thermal nociception 
and a significant loss of intraepidermal nerve fibers.  Electrophysiological investigations of 
skin-nerve preparations identified a reduced rate of action potential discharge in Ins2+/Akita 
mechanonociceptors compared to wildtype littermates, whereas the function of low 
threshold A-fibers was essentially intact. Studies of isolated sensory neurons demonstrated 
a markedly reduced heat responsiveness in Ins2+/Akita DRG neurons, but a mostly unchanged 
function of cold sensitive neurons.  Restoration of normal glucose control by islet 
transplantation produced a rapid recovery of nociception, which occurred before 
normoglycemia had been achieved.  Islet transplantation also restored Ins2
+/Akita
 
intraepidermal nerve fiber density to the same level as wildtype mice, indicating that 
restored insulin production can reverse both sensory and anatomical abnormalities of 
diabetic neuropathy in mice.  The reduced rate of action potential discharge in nociceptive 
fibers and the impaired heat responsiveness of Ins2+/Akita DRG neurons suggests that ionic 
sensory transduction and transmission mechanisms are modified by diabetes. 
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Introduction 
Diabetic sensory neuropathy is a major cause of chronic pain and paraesthesias, but the 
most common symptom is sensory loss, and insensate neuropathy is a dominant risk factor 
for foot ulcers and amputations (1–3).  Rodent models of diabetic neuropathy recapitulate 
many anatomical and sensory abnormalities observed in patients, and thus appear suitable 
for translational mechanistic studies (4,5).  The sensory abnormalities reported from 
different rodent models differ qualitatively, with diabetic rats commonly displaying tactile 
and thermal hypersensitivity, whereas mice usually exhibit loss of sensitivity to mechanical 
or thermal stimulation similar to that seen in patients (3–5). 
Patients with diabetic neuropathy typically display a reduced tactile sensitivity and a 
reduced ability to detect skin cooling and heating (6–8).  A compromised ability to detect 
stimulation with von Frey filaments and to sense vibration are thus important and simple 
diagnostic tools for early signs of diabetic neuropathy (9,10).  In addition to the loss of 
sensation and development of pain and paraesthesias, diabetic neuropathy is characterized 
by reduced nerve conduction velocity, distal fiber loss and reduced axon diameters (11,12).  
The relative importance of abnormalities in sensory transduction, conduction and 
anatomical structure for painful or insensate neuropathy in vivo is currently unclear, but the 
presence of sensory abnormalities cannot be used to discriminate between patients with 
painless and painful diabetic neuropathy (12). 
Here, we present a detailed characterization of sensory neuropathy in the Ins2+/Akita mouse 
using behavioral, cellular and neurophysiological approaches.  Mice that are heterozygous 
for the Ins2
C96Y
 (Ins2
+/Akita
) mutation develop β-cell endoplasmic reticulum-stress, produce 
little insulin and become diabetic soon after weaning (13,14).  The phenotype is more 
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serious in male than female mice (13,14).  Since the Ins2C96Y mutation leads to spontaneous 
development of diabetes, the Akita strain provides a convenient translational model 
suitable for investigations of diabetic complications and islet transplantations (15). 
Relatively little information is available about the sensory phenotype of Ins2+/Akita mice, 
whereas autonomic neuropathy has been examined in more detail previously (16). The 
results reported here show that Ins2+/Akita mice rapidly develop impaired mechanosensation 
following the onset of hyperglycemia, later followed by impaired thermal (hot and cold) 
nociception.  Investigations of skin-saphenous nerve preparations demonstrate a reduced 
rate of action potential discharge in mechanosensitive A- and C-nociceptors at high stimulus 
intensities.  The reduced behavioral sensitivity to noxious heat was associated with a 
reduced proportion of heat-sensitive DRG neurons in Ins2+/Akita mice, as well as a reduced 
[Ca2+]i-response amplitude in heat sensitive neurons. 
 
Materials and methods 
Mice and behavioral tests 
Behavioral experiments were carried out according to the U.K. Home Office Animal 
Procedures (1986) Act.  All procedures were approved by the King’s College London Animal 
Welfare and Ethical Review Body and conducted under the UK Home Office Project License 
PPL 70/7510.  Ins2
+/Akita
 mice were obtained from The Jackson Laboratory (Maine USA, JAX 
stock #003548, MGI: 1857572) and maintained on the C57Bl/6J strain.  Blood glucose was 
monitored routinely by Contour XT blood glucose meter (Bayer Healthcare, UK) or Stat Strip 
Xpress meter and strips (Nova Biomedical, UK). 
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The Randall-Selitto paw-pressure test was performed using an Analgesymeter (Ugo-Basile, 
Italy).  Mice were kept in their holding cages to acclimatize (10–15 min) to the experimental 
room.  The experimenter lightly restrained the mouse and applied a constantly increasing 
pressure stimulus to the dorsal surface of the hind paw using a blunt conical probe.  The 
nociceptive threshold was defined as the force in grams at which the mouse withdrew its 
paw.  A force cut-off value of 150 g was used to avoid tissue injury. 
Tactile sensitivity was assessed using von Frey filaments (0.008-2 g) according to Chaplan’s 
up-down method (17).  Animals were placed in a Perspex chamber with a metal grid floor 
allowing access to their plantar surface and allowed to acclimatize prior to the start of the 
experiment.  The von Frey hairs were applied to the plantar surface of the hind paw with 
enough force to allow the filament to bend, and held static for approximately 2-3 s. The 
stimulus was repeated up to 5 times at intervals of several seconds.  The stimulus interval 
was adapted to allow for the resolution of any behavioral responses to previous stimuli.  A 
positive response was noted if the paw was sharply withdrawn or if the mouse flinched 
upon removal of the hair.  Any movement of the mouse, such as walking or grooming, was 
deemed an unclear response, and in such cases the stimulus was repeated.  If no response 
was noted a higher force hair was tested and the filament producing a positive response 
recorded as the threshold. 
Thermal nociception was examined by lightly restraining the animal and placing one of the 
hind paws onto a cold- or hot-plate maintained at 10°C or 50°C (18,19).  The paw withdrawal 
or escape latency was measured using 30 s as a cut-off to avoid tissue injury. 
Skin-nerve preparations 
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Single fiber recordings were carried out from 18-20 week old adult male littermate Ins2+/+ 
and Ins2
+/Akita
 mice. The saphenous nerve and hind-paw hairy skin were dissected free and 
immediately placed in warm (32°C) oxygenated synthetic interstitial fluid (SIF) containing (in 
mM); 108 NaCl, 3.5 KCl, 0.7 MgSO4, 26.2 NaHCO3, 1.65 NaH2PO4, 9.6 Na-gluconate, 5.55 
glucose, 1.53 CaCl2, buffered to pH 7.4 by bubbling carbogen (95% O2 and 5% CO2).  The skin 
was pinned down, corium side up and the saphenous nerve was placed on a mirrored 
platform covered in paraffin oil in a separate chamber containing a SIF-paraffin oil interface. 
The nerve was desheathed and teased into thin filaments, which were placed onto a gold 
electrode. Electrical signals were recorded using the DAM80 differential amplifier (World 
Precision Instruments), band-pass filtered at 300 Hz and 10 kHz and digitized and stored on 
a computer using the Micro1401 data acquisition unit and SPIKE2, version 8 software 
(Cambridge Electronic Design). Action potentials were also visualized using an oscilloscope 
(Gould, 420 series). 
Receptive fields of mechanosensitive primary afferents located in the hairy skin of the hind 
paw and lower hind limb were identified using a blunt glass rod and thereafter stimulated 
with brief electrical pulses (1ms, Digitimer, DS2) to determine the fiber’s conduction 
velocity. Fibers with conduction velocity below 1.2m/s were classified as C fibers, those 
between 1.2 and 10m/s as Aδ fibers and those with conduction velocity exceeding 10m/s as 
Aβ fibers (20). 
The mechanical threshold of single fibers was assessed by identifying the minimum force 
(delivered as a 2s step, by a computer-driven, feedback-controlled stimulator) required to 
evoke 2 action potentials (21).  Adaptation properties were characterized by applying 15s 
sustained mechanical force 0.5, 1, 2, 4, 5, 10, 15 and 20g with 2 min inter-stimulus intervals 
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to reduce tachyphylaxis. The encoding properties of mechano-sensitive Aδ and C fibers were 
examined by applying ramp shaped mechanical stimuli.  
The thermal sensitivity of some C fibers was investigated. A metal ring was used to isolate 
the receptive field and a 60 second cold stimulus ~31 to 4°C was applied by superfusing pre-
cooled SIF. Thereafter, a 20 second heat stimulus of ~32 to 48°C was applied by pre-
warming the SIF through a heated-element. The rate of temperature increase was 
determined using a custom-made feedback-controlled device. For both the cold and heat 
stimuli, peristaltic pumps were used to control the SIF flow rate. A digital temperature 
probe was placed inside the ring to record the temperature (Greisinger, GIA 2000) at the 
skin. A thermally elicited response was considered if a minimum of two action potentials 
occurred and the temperature at which the second action potential fired was recorded as 
the thermal threshold. 
Data were analyzed offline using the SPIKE2 software (Cambridge Electronic Design). Action 
potentials were discriminated using templates based on their amplitude and waveform. 
DRG neurons 
DRG neurons were dissociated enzymatically (using collagenase and trypsin) from ganglia 
dissected from 12 (1 of each phenotype) or 20 weeks old (2-3 of each genotype) male 
littermate Ins2+/+ and Ins2+/Akita mice using methods described previously (22). Isolated 
neurons were plated on poly-d-lysine coated coverslips and maintained at 37°C in 95% air, 
5% CO2. Wildtype (Ins2
+/+) neurons were maintained in MEM AQ containing 5.6 mM glucose 
(Sigma, Poole, UK) and Ins2+/Akita neurons in DMEM glutamax containing 25 mM glucose 
(Thermofisher, UK), each supplemented with 10 % fetal bovine serum, 100 U/ml penicillin, 
100 μg/ml streptomycin, 10 μM cytosine arabinoside and 50 ng/ml NGF (Promega, 
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Southampton, UK) for up to 24 hours before experimentation.  The serum content of insulin 
makes the final concentration in medium 4pM, a concentration far below that required to 
support trophic effects on isolated DRG neurons (23). 
Intracellular [Ca
2+
]i-measurements 
DRG neurons were loaded with 2.5 µM fura-2 AM (Invitrogen) in the presence of 1 mM 
probenecid and 0.01% pluronic acid for approximately one hour at 37°C. In all experiments 
the cells were constantly superfused with physiological saline solution containing (in mM) 
140 NaCl, 5KCl, 10 Glucose, 10 HEPES, 2 CaCl2 and 1 MgCl2, pH 7.4 (NaOH). Fura-2 was 
excited at wavelengths of 340 and 380 nm and light emission measured at wavelengths 
>520nm.  Solutions were applied through a tube placed in close proximity of the cells and 
ratio images were captured every 2 s. Data were analysed using ImageMaster software (PTI, 
New Jersey, USA) to obtain emission intensity ratios (R(340/380))  in individual cells. 
Intraepidermal nerve fibers 
Hind paw skin was dissected and fixed in 4 % paraformaldehyde (PFA) in phosphate-
buffered saline and kept at room temperature until embedded in paraffin wax. 8 µm thick 
sections were cut and stained with rabbit polyclonal anti-PGP9.5 (Ultraclone Ltd, UK) 
overnight at 4 °C. Staining was visualized using a biotinylated goat anti-rabbit lgG 
(Vectorlabs), followed by streptavidin-Alexa 568 (Invitrogen). Skin sections were additionally 
stained with DAPI to visualize nuclei. The high density of nuclei in the epidermis provides a 
clear indication of the location of the basement membrane.  We have adapted the general 
method described for human tissue (24,25) to suit thin sections prepared from mouse skin 
(26,27). The number of intraepidermal nerve fibers extending intact from the basement 
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membrane per mm was quantified using a Zeiss Apotome microscope.  The observer was 
blinded to the identity of the animal. 
Islet isolation and transplantation 
Islets were isolated from 10-12 week old C57Bl/6J mice (Charles River, UK) using collagenase 
digestion (1mg/ml, type XI, Sigma Aldrich, UK) and density gradient separation (Histopaque-
1077, Sigma Aldrich, UK) as previously described (28). Islets were washed in culture medium 
(RPMI-1640 supplemented with 10% Foetal Bovine Serum and 1% Penicillin/Streptomycin) 
and divided into groups of 500 for same day transplantation. 
Male 14-20 week old Ins2+/Akita mice were transplanted with 500 freshly isolated islets into 
the renal subcapsular space. Mice were anaesthetized with 1–5% isoflurane and 95% oxygen 
(1l/min). The kidney was exposed by a lumbar incision and a small perforation in the kidney 
capsule was made using a 23G needle. Islets were pelleted in PE50 tubing before being 
injected under the renal capsule using a Hamilton syringe (Hamilton, USA). The capsule was 
then cauterized and the mouse peritoneum and skin were sutured. Mice were given 
carprofen (Caprieve, 4mg/k.g; s.c.; Norbrook, UK) and bupivacaine (Marcaine 0.5% solution, 
2mg/kg, s.c., Aspen Medical, UK) for post-operative analgesia. 
Data analysis 
Quantitative data are presented as the individual raw data points or mean ± SEM, and the 
number of observations (animals or cells indicated by n). Data were analyzed by t-test, 
Mann-Whitney U-test or ANOVA followed by Tukey’s post-hoc test as appropriate.  
Categorical data were analyzed by Fisher’s exact test. Boxplots show the median, 
interquartile range, with whiskers indicating the 5
th
 and 95
th
 percentile.  Statistical analysis 
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was performed using Statistica or IBM SPSS (version 20 or higher).  Differences were 
considered significant at p<0.05. 
Drugs and Chemicals 
Icilin was purchased from Tocris (Bristol, UK), salts and all other reagents from Sigma-Aldrich 
(Gillingham, UK), unless stated otherwise. 
Results 
Diabetes in Ins2
+/Akita 
Ins2
+/Akita
 mice developed hyperglycemia soon after weaning and became diabetic around 4-
5 weeks of age (Fig. 1A).  Hyperglycemia progressively worsened in male Ins2+/Akita mice, and 
around 12 weeks of age, their blood glucose values reached or exceeded the upper limit of 
most blood glucose meters (~33 mM).  In contrast, blood glucose peaked around 6 weeks of 
age in female Ins2+/Akita mice, and thereafter declined towards normoglycaemia.  Male, but 
not female Ins2
+/Akita
 mice gained body weight at a reduced rate compared to wildtype 
littermates (Fig. 1B). 
Nociception in the Ins2
+/Akita
 mouse 
We assessed the behavioral sensitivity of male and female, wildtype and Ins2
+/Akita
 mice to 
noxious mechanical and thermal stimulation, starting soon after weaning and continuing 
until ~20 weeks of age.  Mechanical nociception was assessed using the Randall-Selitto paw 
pressure test and punctate stimulation with von Frey filaments, and the sensitivity to 
noxious thermal stimulation was determined using a modified cold- and hot-plate assay 
(18,19).  Both male and female Ins2+/Akita mice developed a reduced sensitivity in the paw-
pressure test, almost immediately after the onset of hyperglycemia (Fig. 1C).  Furthermore, 
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female Ins2+/Akita mice progressively recovered from mechanical insensitivity from about 10-
12 weeks, when their blood glucose concentration started to decline.  From 14 weeks of 
age, female Ins2+/Akita mice were no longer distinguishable from wildtype littermates in the 
paw-pressure test, suggesting that the glycemic profile has a dynamic influence on 
mechanical nociception in mice (Fig. 1C).  The paw withdrawal threshold in response to 
stimulation with calibrated von Frey filaments did not differ between Ins2+/Akita and wildtype 
littermates, apart from a transiently reduced sensitivity in male Ins2+/Akita mice around 10 
weeks of age (Fig. 1D). 
The paw withdrawal latency of male Ins2+/Akita mice in the cold (10°C) and hot (50°C) plate 
tests increased at around 9-10 weeks of age and thereafter remained elevated until at least 
19-20 weeks of age (Fig. 1e, f).  In contrast, female Ins2+/Akita mice remained 
indistinguishable from wildtype mice in both thermal tests, apart from a transiently reduced 
cold sensitivity around 10 weeks of age (Fig. 1 e, f). The paw-pressure thus appears to be a 
particularly sensitive parameter for assessing sensory abnormalities in diabetic mice, and 
our results indicate that the degree of hyperglycemia experienced by female Ins2+/Akita mice 
is not sufficient to influence the behavioral sensitivity to noxious hot or cold stimulation.  
Low-threshold mechanoreceptors 
The conduction velocities and the mechanical response thresholds of rapidly adapting (RA), 
slowly adapting (SA) Aβ and Aδ down hair (DH) fibers were unchanged in preparations from 
18-20 weeks old male diabetic Ins2+/Akita mice compared to fibers in age-matched male WT 
littermates (table 1).  Furthermore, RA and DH fibers from diabetic Ins2+/Akita mice displayed 
an unchanged action potential firing pattern to sustained force across the range of forces 
tested (0.5-20g) compared to fibers in preparations from wildtype littermates (Fig. 2A, B, E, 
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F).  We did note a significantly reduced firing rate in Ins2+/Akita SA fibers in response to the 
lowest force (0.5g, p= 0.01, Mann-Whitney U-test, Fig 2C). This observation suggests that SA 
fibers in Ins2+/Akita mice display an accelerated adaptation at low stimulus strengths, 
compared to WT mice (Fig 2D).  
Aδ- and C-mechanoreceptors 
The conduction velocities of Ins2+/Akita nociceptive Aδ-mechanoreceptors (AM, (29)) were 
unchanged compared to WT fibers in preparations from 20 week old male mice. 
Unmyelinated C-mechanoreceptors (CM, (30)) from Ins2
+/Akita
 however displayed a reduced 
conduction velocity compared to WT fibers (p=0.007, Mann-Whitney U-test, Table 1), as 
previously noted in diabetic rats (31).  The response threshold in AM fibers from diabetic 
mice was modestly increased (Table 1), but the most striking differences between the 
response properties of nociceptors from Ins2+/Akita and wildtype mice were revealed by 
suprathreshold stimulation.  Wildtype AM fibers faithfully encoded mechanical force with a 
linear increase in discharge rate. In contrast, fibers from Ins2+/Akita mice failed to encode 
stimuli exceeding 10g (Fig. 3A) and displayed a significantly reduced impulse rate in 
response to the highest mechanical forces (Fig 3A, D).  The temporal response profiles 
evoked by force steps, demonstrates that Ins2+/Akita AM fibers failed to reach the maximal, 
initial impulse rate typical of WT fibers (Fig 3B, C).  The mechanical encoding properties of 
AMs were examined further using ramp-shaped stimuli.  Diabetic AM fibers displayed a 
marginally (but not significantly) reduced average firing frequencies throughout the range of 
ramp forces used (Fig. 3E, F), an observation which may be consistent with a failure to 
achieve the initial peak firing rate (Fig. 3C), but a retained ability to encode force in response 
to continuously increasing ramp stimulation. 
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Stimulation with force steps produced similar impulse discharge rates in CM fibers from 
wildtype and Ins2
+/Akita
 mice (Fig 4A, B), but responses to the maximal ramp force was 
significantly reduced in Ins2+/Akita CM fibers (Fig. 4C).  Although Ins2+/Akita CM fibers encoded 
the intensity of a ramp force stimulus, they appeared to do so at somewhat lower rate than 
CM fibers in wildtype preparations (Fig. 4D, E).  
Heat and cold sensitivity of Ins
2+/Akita
 C-mechanoreceptors 
Since diabetic mice displayed behavioral insensitivity to noxious heat and cold, we 
investigated whether the thermal sensitivity of C-mechanoreceptors was altered in Ins2
+/Akita
 
mice. The proportion of C-fiber nociceptors that responded to cold (WT; 48%, n=14/29 vs 
Ins2
+/Akita; 48%, n=12/25, p=0.98, Pearson’s Chi-Squared test) or heat (WT; 51%, n=15/29 vs 
Ins2
+/Akita; 45%, n=9/20, p=0.64, Pearson’s Chi-squared test) was unchanged in Ins2+/Akita 
compared to WT littermates.  Cold sensitive nociceptors (CMC fibers) from diabetic mice 
exhibited a marginally, but not significantly, reduced temperature threshold for activation 
(Ins2+/Akita 18.2 ± 2°C; WT 21.4± 1.7°C, p=0.25, Mann-Whitney U-test, Fig. 5 AB). Cold 
stimulation evoked a significantly reduced number of action potentials in CMC fibers from 
Ins2
+/Akita
 compared to WT mice (Ins2
+/Akita
 18± 4; WT 37± 7 action potentials, respectively, 
p=0.018, Mann-Whitney U-test, Fig. 5 C-E).  Similarly, heat sensitive nociceptors (CMH 
fibers) from diabetic mice displayed slightly, but not significantly, higher thresholds for heat 
activation (Ins2
+/Akita
 40.4 ± 1.2°C; WT 38.4± 1.0°C, p=0.14, Mann-Whitney U-test, Fig. 5 FG) 
and a reduced number of action potentials in CMH fibers from Ins2+/Akita compared to WT 
(Ins2+/Akita;16± 5; WT 25± 5 action potentials, respectively, p=0.18, Mann-Whitney U-test, 
Fig. 5 H-J).  
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Heat and cold sensitivity of Ins2
+/Akita
 DRG neurons  
We used [Ca
2+
]i-imaging to determine whether the behavioral insensitivity of Ins2
+/Akita
 mice 
to noxious heat and cold was associated with a compromised thermal sensitivity of isolated 
DRG neurons (Fig. 6A, B).  These experiments were performed on neurons isolated from 12 
or 20 weeks old male wildtype and Ins2
+/Akita
 mice.  Stimulation with heat ramps (from 25 to 
48°C) evoked [Ca2+]i-responses in a significantly reduced proportion of DRG neurons from 
Ins2
+/Akita mice compared to neurons isolated from wildtype mice (Ins2+/Akita 19.3% 428 of 
2222, n=4 animals; wildtype mice 28.5%, 300 of 1054, n=3 animals, Fisher`s exact test 
P<0.001).  Our measurements revealed a modestly, but significantly, reduced temperature 
threshold for heat activation in neurons from diabetic mice (Ins2+/Akita 41.5 ± 0.2°C; wildtype 
42.9 ± 0.2°C, Fig. 6C; t-test, P<0.001).  The heat-evoked [Ca2+]i-response amplitude was 
reduced by 40% in neurons from Ins2+/Akita mice compared to wildtype (Ins2+/Akita 0.77 ± 0.02 
R(340/380); wildtype mice 1.2 ± 0.04 R(340/380); Fig. 6D; t-test, P<0.001).  These results strongly 
suggest that an impaired neuronal transduction of noxious heat may contribute to the 
behavioral insensitivity observed in vivo.  The proportion of neurons responding to the 
TRPV1 agonist 1μM capsaicin (Ins2
+/Akita
 44.3%, 759 of 1715 neurons, wildtype 42.4%, 447 of 
1054, P>0.3, Fisher’s exact test) and the response amplitude evoked by capsaicin were 
indistinguishable in cultures from wildtype and Ins2+/Akita mice, indicating that the reduced 
heat responsiveness of Ins2
+/Akita
 DRG neurons is not likely due to an altered expression of 
the noxious heat transducer TRPV1. 
In contrast to the reduced heat sensitivity of Ins2+/Akita DRG neurons, cold ramps (35-10°C) 
elicited indistinguishable [Ca
2+
]i-responses in neurons isolated from mice of the two 
genotypes.  Cooling stimulated [Ca2+]i-responses in a small proportion of DRG neurons from 
20 weeks old Ins2+/Akita (2.4%, 55 of 2318) and wildtype littermates (2.5 %, 40 of 1604).  
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Cold-evoked [Ca2+]i-response amplitudes did not differ between neurons of the two 
genotypes (Fig. 6F), whereas the cold activation temperature was marginally, but 
significantly, higher in Ins2+/Akita neurons (24.5 ± 0.7 °C) compared to wildtype neurons (22.3 
± 0.9 °C; Fig. 6E).  These results indicate that the behavioral insensitivity to noxious cold 
observed in diabetic Ins2
+/Akita
 mice is not associated with compromised cellular cold 
transduction mechanisms.  
Reduced cutaneous innervation in diabetic Ins2
+/Akita
 mice 
Diabetic neuropathy is accompanied by a loss of intraepidermal nerve fibers (IENFs) in 
patients and in animal models of diabetes, a feature which is frequently used as a diagnostic 
tool in various small fiber neuropathies (25,32,33).  Plantar skin sections prepared from 
male 20 weeks old diabetic Ins2+/Akita mice and wildtype littermates were 
immunohistochemically labelled for expression of the pan-neuronal marker PGP9.5 (Fig. 
7A).  We measured the IENF density by counting the number of nerve fibers (mm
-1
) that 
extended intact from the epidermal/dermal junction into the epidermis, in thin (8 µm) 
paraformaldehyde-fixed paraffin-embedded sections of plantar skin (24,25,32).  Our results 
revealed a significant loss of IENFs in diabetic mice.  Compared to paw skin from wildtype 
littermates, the density of PGP9.5-positive epidermal fibers was reduced by about a third in 
diabetic Ins2+/Akita mice (Fig. 7B).  
Islet transplantation rapidly reversed symptoms of sensory neuropathy 
Finally, we examined whether the impaired nociception and loss of intraepidermal nerve 
fibers in Ins2+/Akita mice could be reversed by improved glycemic control. A group of diabetic 
Ins2
+/Akita
 mice underwent transplantation of pancreatic islets obtained from healthy 
C57Bl/6J mice (500 islets under the kidney capsule).  Following transplantation, blood 
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glucose declined steadily during the first few days after transplantation, followed by a 
slower phase of decline and at 3 weeks after islet implantation all mice had glucose levels 
<15mM (Fig. 7C).  Intriguingly, nociception improved rapidly and significantly following 
transplantation (Fig. 7DE).  The behavioral sensitivity to noxious mechanical and cold 
stimulation recovered to the same level as in naïve wildtype mice within a few days of 
transplantation, and thus occurred before normoglycemia was established.  The IENF 
density in paw skin from transplanted mice had increased significantly at the end of the 
experiment (5-6 weeks after transplantation) compared to Ins2
+/Akita
 mice that had not 
received an islet transplant.  The IENF density in transplanted mice was indistinguishable 
from that in healthy wildtype mice (Fig. 7B).  
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DISCUSSION 
Here, we present a detailed characterization of sensory neuropathy in the Ins2
+/Akita
 mouse, 
and demonstrate that diabetes leads to an impaired mechanical and thermal (hot and cold) 
nociception, which is associated with a marked loss of IENFs.  We noted a rapid loss of 
mechanical nociception at the onset of diabetes, which was followed by a reduced 
sensitivity to noxious cold and heat 2-3 weeks later.  In contrast, we did not observe an 
altered sensitivity to stimulation with von Frey filaments.  We used manual stimulation with 
calibrated von Frey filaments according to Chaplan’s up-down method (17), rather than the 
widely used automated von Frey assay (5), which employs stimuli of higher force intensity 
and generates higher paw withdrawal thresholds.  Our behavioral and electrophysiological 
studies suggest that mechano-nociceptors are particularly sensitive to diabetes, whereas 
low-threshold A-fibers are functionally more resilient.  Intriguingly, the loss of mechanical 
nociception appears to be a dynamic process, with rapid onset after the establishment of 
hyperglycemia, and a similarly rapid recovery following islet transplantation.  In addition, 
the recovery of female Ins2+/Akita mice from hyperglycemia was accompanied by a 
normalized sensitivity in the paw-pressure test.  The distinct behavioral profiles observed 
using different test modalities underscores the value of employing a comprehensive 
behavioral testing strategy. 
Mechanosensation 
Patients with diabetic neuropathy commonly report numbness, spontaneous pain and 
dysesthesias (34), but loss of thermal (cold and heat detection) and mechanical (mechanical 
and vibration detection) sensation are the dominant sensory symptoms in patients with 
mild, severe or no pain (3,35).  Hypersensitivity to thermal or mechanical stimulation 
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(evoked pain) can thus not be viewed as translational measures of spontaneous pain or 
painful diabetic neuropathy.  Importantly, we only observed a reduced responsiveness of 
mechanosensitive and thermosensitive fibers here, in good agreement with an earlier skin-
nerve investigation of mice made diabetic by STZ treatment (36). 
Our electrophysiological studies demonstrate that Ins2
+/Akita
 AM and, to a lesser extent, CM 
nociceptors failed to sustain a high action potential discharge rate in response to intense 
mechanical stimulation.  The force activation threshold of Ins2+/Akita AM fibres, but not CM 
fibers, was increased somewhat compared to fibers from wildtype mice, whereas C-fibers 
exhibited a degree of conduction slowing. Together, these results suggest that neuronal 
excitability and conduction, rather than transduction of mechanical and thermal stimuli, are 
primarily affected by diabetes in Ins2+/Akita mice. Our results are consistent with the loss of 
mechanical nociception observed in mice in vivo and clinically in patients (1,37,38).   
Earlier investigations of STZ induced diabetic neuropathy in mice, demonstrated a reduced 
mechanical sensitivity of RA fibers, and a more pronounced loss of CM nociceptor activity 
than observed here in Ins2+/Akita mice (36).  It is possible that the longer interval between 
consecutive mechanical challenges used here may have allowed a fuller recovery of CM 
fiber activity.  Other possible reasons for differences between the two studies include the 
age of diabetes onset (which is very early in Ins2+/Akita), duration of diabetes, and the 
possibility that STZ affects cells outside the pancreatic islets (39–42). 
Thermal nociception 
Diabetic Ins2+/Akita mice displayed an impaired sensitivity to noxious heat and cold in vivo 
and in vitro.  Studies of temperature sensitive CM fibers (CMHs and CMCs) in isolated skin-
nerve preparations from Ins2+/Akita mice, demonstrated a markedly reduced responsiveness 
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to cold, but not to heat.  DRG neurons from Ins2+/Akita mice showed a markedly reduced heat 
responsiveness compared to neurons from wildtype mice, but an unchanged cold sensitivity. 
The capsaicin receptor TRPV1 is the principal heat transducer in DRG neurons, although 
other ion channels have been proposed to contribute to transduction of noxious heat, e.g. 
during inflammation or in response to very high temperatures (43–46).  A high 
concentration of the TRPV1 agonist capsaicin evoked [Ca2+]i-responses in equal proportions 
of wildtype and Ins2+/Akita DRG neurons, suggesting that an altered expression of TRPV1 is 
unlikely to explain the reduced heat sensitivity in Ins2
+/Akita
.  It is possible that a reduced 
activity produced by e.g. glycation (47) or altered phosphorylation of TRPV1 may contribute 
to the reduced sensitivity (48).  It is likely that heat evoked [Ca2+]i-responses are mediated in 
part by voltage gated Ca2+-channels, following an initial TRPV1 mediated depolarization. An 
altered activity of voltage gated channels or differences in membrane potential that 
influences calcium entry via voltage-gated calcium channels, may thus be responsible for the 
reduced heat sensitivity observed in DRG neurons isolated from Ins2+/Akita mice.  The 
reduced heat responsiveness of isolated DRG neurons, but largely unchanged activity of 
CMH fibers, may indicate that mechano-insensitive heat nociceptors are affected by 
diabetes. 
In contrast to the reduced heat responsiveness of Ins2+/Akita DRG neurons, we did not detect 
any deficits in the neuronal response to cold ramps.  We used a modest cooling rate in our 
experiments, and different rates of cooling are known to stimulate different sensory neuron 
populations (49,50).  It is therefore possible that a sub-population of cold-sensitive Ins2+/Akita 
DRG neurons with altered properties may have been overlooked. 
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Nociceptive AM and CM fibers, as well as mechanically insensitive thermoreceptors 
terminate as free nerve endings in the epidermal layer of the skin (51,52).  A reduced density 
of IENFs may thus have contributed to the impaired thermal and mechanical nociceptive 
function in vivo. 
Islet transplantation 
Transplantation of pancreatic islets isolated from healthy wildtype mice, progressively 
improved blood glucose and achieved normoglycemia after about three weeks.  In contrast, 
the behavioral sensitivity to noxious mechanical and cold stimulation was restored to the 
wildtype level by the time of first behavioral test (2-3 days after transplantation).  This rapid 
recovery of sensory function, may indicate that hyperglycemia is not directly responsible for 
maintaining the impaired nociception.  One possible explanation for the rapid restoration of 
nociceptive function is that insulin itself may modulate sensory neuron function and act as a 
neurotrophic factor (reviewed in (53)).  A rapid neurotrophic or sensitizing effect of insulin 
on sensory neurons following transplantation, is also consistent with the observation that 
the insulin signal transduction machinery is intact or even upregulated in Zucker diabetic 
fatty rats with well-established neuropathy (54).  Furthermore, local intraplantar 
administration of insulin in diabetic mice rapidly (within days) increased the density of 
IENFs, a time course that is consistent with that observed here for recovery of behavioral 
sensitivity in vivo following islet transplantation (55).  In our experiments on isolated DRG 
neurons, we did not match the insulin concentrations to the levels that the DRG neurons 
would experience in vivo. The observed differences between wildtype and Akita neurons 
can thus not be explained by any differences in the insulin concentrations in the cell culture 
medium.  Importantly, this also means that the compromised heat sensitivity of Ins2+/Akita 
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neurons, which are in line with our behavioral observations in vivo and electrophysiological 
observations in vitro, are due to diabetes, not simply due to differences in insulin signaling 
after isolation of the neurons. It is likely that sensory neurons exhibit heterogenous insulin 
signaling mechanisms, since the expression pattern of the insulin receptor, IRS1 and IRS2 
isn’t uniform across DRG neurons (56).  The concentration of insulin present in the medium 
here (~4pM) is below the concentrations required to exert trophic effects on isolated 
sensory neurons (23). 
In conclusion, diabetes caused by Ins2
C96Y
 is associated with impaired nociception, loss of 
IENFs, a reduced sensory neuronal heat sensitivity and a reduced action potential discharge 
rate in mechanosensitive nociceptive afferent fibers in vitro. Functional and structural 
improvement from established diabetic neuropathy was previously reported from mice that 
recovered spontaneously from STZ-evoked diabetes (57). Our results highlight the 
importance of distinguishing sensory abnormalities from the spontaneous pain that may be 
caused by diabetic neuropathy in patients. Islet transplantation restored IENF density 
(assessed at the end of the experiment, 5-6 weeks after transplantation).  Remarkably, islet 
transplantation restored nociceptive function before normoglycemia was established, 
indicating that lack of insulin, rather than hyperglycemia per se, is responsible for the 
impaired nociception in diabetic mice.   
Ins2
+/Akita
, and other strains carrying Ins2 mutations (58), are convenient and attractive 
models of type 1 diabetes.  Here we show that diabetic neuropathy in the Ins2+/Akita mouse is 
characterized by a loss of evoked sensory responses, consistent with the sensory profile 
most commonly observed in patients with painful or painless neuropathy (3).  Studies of 
experimental models which rely on disease relevant mechanisms and faithfully reproduce 
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the clinical condition, such as the Ins2+/Akita mouse, are likely to generate conclusions of 
translational predictive validity.  Ins2
+/Akita
 appears to have an advantage over several other 
commonly used rodent models of diabetic sensory neuropathy that are associated with 
mechanical hypersensitivity.  The hypersensitivity seen in the latter models contrasts with 
clinical experience in humans where reduced tactile sensitivity is used to detect the onset of 
diabetic neuropathy.  Although patients with painful diabetic neuropathy may display a 
more marked loss of sensation than those with painless neuropathy, sensory loss is the 
primary symptom of both groups (3,35,38).  Sensory testing of diabetic rodents is thus 
appropriate as a sensitive experimental measure of sensory neuropathy, but not as a 
translational measure of spontaneous pain and dysesthesias. 
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FIGURE LEGENDS 
Figure 1. Diabetes and nociception in Ins2
+/Akita
 mice.  Blood glucose (A) and body weight 
(B) was monitored weekly in male and female Ins2+/Akita and wildtype littermates.  
Mechanical nociception was monitored using the paw-pressure test (C) and punctate 
stimulation with von Frey filaments (D).  Thermal nociception was examined using cold (10 
°C) and hot (50 °C) plate tests.  *P<0.05, **P<0.01 and ***P<0.001, compared to wildtype 
mice of the same sex, ANOVA followed by Tukey’s.  N=3-20 (3 for some measurements at 3-
4 and 18< weeks of age). 
Figure 2. Diabetes has a limited impact on low threshold mechanoreceptors. The number 
of action potentials elicited per second by a 15 s force step in skin-nerve preparations from 
20 weeks old male WT and Ins2+/Akita mice is shown for RA, SA and D-hair fibers. (A) RA and 
(E) D-hair fibers from Ins2+/Akita and wildtype littermates responded similarly in response to 
all forces. The temporal response pattern to sustained stimuli was indistinguishable 
between wildtype and Ins2+/Akita RA (B) and D-hair (F) fibers, with high rates of action 
potentials at the force onset and offset. The mean response to 0.5 g constant force is 
shown. (C) Diabetic SA fibers responded significantly less to the lowest force of 0.5g (p=0.01, 
Mann-Whitney U-test). (D) Diabetic SA fibers showed a reduced firing rate after the first 
second to a 0.5g sustained force. **p<0.01, compared to SA fibers from wildtype mice, 
Mann-Whitney U-test. 
Figure 3. Aδ mechano-nociceptors are impaired in diabetic Ins2
+/Akita
 mice.  (A) Ins2+/Akita 
AM fibers displayed a reduced rate of action potential discharge in response to 15s 
applications of 15g and 20g force, compared to wildtype fibers (p=0.008 for 15g, p=0.0012 
for 20g, Mann-Whitney U-test). (B) Ins2+/Akita AM fibers display a reduced rate of firing in 
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response to application of 20g force, with a particularly marked reduction during the first 
few seconds of the stimulus. (C) WT AM fibers attained significantly higher maximal firing 
rates in response to applications of both 15 and 20g (p=0.002 for 15g and p=0.005 for 20g, 
Mann-Whitney U-test) compared to diabetic AM fibers. (D) Example traces of Ins2+/Akita and 
wildtype AM fibers demonstrating the markedly reduced response rate in diabetic AM 
fibers. (E) Ins2+/Akita and wildtype AM fibers responses evoked by increasing force ramps. (F) 
The temporal pattern of impulse discharge rates evoked by 20g force ramps in Ins2+/Akita and 
wildtype AM fibers. * p<0.05; **p<0.01, compared to wildtype, Mann-Whitney U-test.  All 
fibers were recorded in preparations from 20 weeks old male mice. 
Figure 4. C mechano-nociceptors are impaired in diabetic Ins2
+/Akita
 mice.  The rate of 
action potential discharge evoked by 15s force steps (A), and the mean temporal discharge 
pattern produced by 20g steps (B) in Ins2+/Akita and wildtype CM fibers are shown. (C) 
Application of force ramp stimuli evoked a significantly reduced rate of impulse discharge in 
Ins2
+/Akita compared to WT CM fibers at 20g, with a pattern of reduced response rates at 
lower ramp forces (p=0.035, Mann-Whitney U-test). (D) The mean firing patterns evoked by 
stimulation of Ins2
+/Akita
 and WT CM fibers with 20g ramps, show that diabetic CM fibers 
respond with reduced discharge rates throughout the stimulus, particularly in response to 
the peak force at the end of the challenge. (E) Typical traces of the response of Ins2+/Akita 
and WT CM fibers illustrate that diabetic CM fibers produce fewer action potentials in 
response to application of 20g force ramps.  * p<0.05; **p<0.01, compared to wildtype, 
Mann-Whitney U-test. All fibers were recorded in preparations from 20 weeks old male 
mice. 
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Figure 5. Temperature evoked responses in C-mechano nociceptors. Distribution of 
temperature thresholds and the temperature change required to elicit cold (A and B) and 
heat activation (F and G) in Ins2+/Akita and wildtype C-mechano nociceptors is shown. The 
number of cold evoked action potentials was significantly reduced in CM nociceptors from 
Ins2
+/Akita
 mice compared to wildtype mice as shown by the average response to a 60 second 
cold ramp (C) and their response pattern (D). An overall reduction in heat evoked action 
potentials from Ins2+/Akita mice was observed compared to wildtype mice (H and I), but the 
difference did not reach statistical significance. (E and J) Example traces of a wildtype and 
diabetic CM nociceptors responding to cold and heat, respectively is shown. *P<0.05, 
compared to wildtype, Mann-Whitney U-test, the numbers of studied fibers in the different 
categories are indicated in panels D and I. All fibers were recorded in preparations from 20 
weeks old male mice. 
Figure 6.  Temperature evoked responses in DRG neurons. (A) DRG neurons loaded with 
Fura-2 were challenged with cold and heat followed by the TRPM8 agonist icilin (1 μM), the 
TRPV1 agonist capsaicin (1 μM) and KCl (50 mM).  The black trace is an example of a typical 
icilin- and cold-sensitive neuron.  This neuron exhibits an off-response after the heat ramp, 
when the temperature is returned to ~30 °C.  The red trace is an example of a heat- and 
capsaicin-sensitive neuron.  (B) Neurons that responded to a temperature ramp with a 
discontinuous rate of [Ca
2+
]i-increase were considered heat/cold sensitive and included in 
the analysis.  Distribution of temperature thresholds for heat activation (C) and cold 
activation (E) in Ins2+/Akita and wildtype neurons.  (D) Heat evoked [Ca2+]i-response 
amplitudes were reduced in neurons from Ins2
+/Akita
 mice compared to wildtype mice, 
whereas the amplitude of cold responses were unchanged (F). *P<0.05, ***P<0.001, 
unpaired t-test.  DRG neurons were isolated from male mice of 12 or 20 weeks of age. 
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Figure 7.  Recovery from sensory neuropathy following islet transplantation.  (A) 
Intraepidermal nerve fibers (IENFs) were visualized by immunostaining for PGP9.5. The 
scalebar is 20μm. (B) The IENF density was significantly reduced in skin sections from male 
20 weeks old Ins2+/Akita mice compared to age-matched wildtype littermates.  Male diabetic 
Ins2
+/Akita
 mice were transplanted at an age of 14-20 weeks.  Following islet transplantation 
(5-6 weeks), the IENF density recovered to the level seen in healthy wildtype mice.  (C) 
Blood glucose concentration was progressively restored following islet transplantation, 
reaching normoglycemic levels after 2-3 weeks.  (D) The sensitivity to noxious mechanical 
(paw-pressure test) and (E) cold (cold-plate) stimulation rapidly increased to wildtype level 
following islet transplantation (compare to wildtype in Fig. 1C, E).  Individual data points 
from each of n=5 transplanted mice are shown in C-E. The areas shaded in grey (C-E) 
indicate the level in male wildtype littermates (mean ± SD).  Data in B are the individual raw 
values and the box indicates median with interquartile range of n=5-7 mice. *P<0.05, 
**P<0.01, ***P<0.001, ANOVA followed by Tukey’s (compared to Ins2+/Akita panel B) or 
Dunnett’s (compared to pre-transplantation, panels C-E) post-hoc test. 
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Table 1. Sensory nerve fiber conduction velocity and mechanical thresholds in male 20 
weeks old WT and diabetic Ins2
+/Akita 
mice 
Values are mean ± SEM (n), P values from Mann-Whitney U-test. 
Fiber type WT 
conduction 
velocity 
(m/s)  
Ins2
+/Akita
 
conduction 
velocity 
(m/s)  
P 
values 
WT 
mechanical 
threshold (g)  
Ins2
+/Akita
 
mechanical 
threshold (g) 
P 
values 
Aβ rapidly 
adapting 
14.3 ± 1.1, 
(20) 
13.4 ± 0.7, 
(10) 
0.71 0.5 ± 0.2, 
(14) 
0.7 ± 0.3, 
(10) 
0.84 
Aβ slowly adapting 15.8 ± 1.0, 
(21) 
15.5 ± 2.0, 
(9) 
0.44 0.4 ± 0.1, 
(12) 
0.5 ± 0.1,  
(9) 
0.23 
Aδ down hair 7.5 ± 0.3, 
(16) 
6.4 ± 0.6, 
(11) 
0.27 0.2 ± 0.04, 
(12) 
0.2 ± 0.1, 
(11) 
0.34 
Aδ A-
mechanoreceptor 
5.9 ± 0.4, 
(38) 
6.8 ± 1.0, 
(12) 
0.47 2.3 ± 0.3, 
(32) 
2.9 ± 0.3, 
(12) 
0.037 
C-
mechanoreceptor 
0.57 ± 0.02, 
(45) 
0.49 ± 0.02, 
(28) 
0.007 2.3 ± 0.2, 
(35) 
3.0 ± 0.5, 
(24) 
0.9 
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Figure 1. Diabetes and nociception in Ins2+/Akita mice.  Blood glucose (A) and body weight (B) was 
monitored weekly in male and female Ins2+/Akita and wildtype littermates.  Mechanical nociception was 
monitored using the paw-pressure test (C) and punctate stimulation with von Frey filaments (D).  Thermal 
nociception was examined using cold (10 °C) and hot (50 °C) plate tests.  *P<0.05, **P<0.01 and 
***P<0.001, compared to wildtype mice of the same sex, ANOVA followed by Tukey’s.  N=3-20 (3 for some 
measurements at 3-4 and 18< weeks of age).  
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Figure 2. Diabetes has a limited impact on low threshold mechanoreceptors. The number of action potentials 
elicited per second by a 15 s force step in skin-nerve preparations from 20 weeks old male WT and 
Ins2+/Akita mice is shown for RA, SA and D-hair fibers. (A) RA and (E) D-hair fibers from Ins2+/Akita and 
wildtype littermates responded similarly in response to all forces. The temporal response pattern to 
sustained stimuli was indistinguishable between wildtype and Ins2+/Akita RA (B) and D-hair (F) fibers, with 
high rates of action potentials at the force onset and offset. The mean response to 0.5 g constant force is 
shown. (C) Diabetic SA fibers responded significantly less to the lowest force of 0.5g (p=0.01, Mann-
Whitney U-test). (D) Diabetic SA fibers showed a reduced firing rate after the first second to a 0.5g 
sustained force. **p<0.01, compared to SA fibers from wildtype mice, Mann-Whitney U-test.  
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Figure 3. Aδ mechano-nociceptors are impaired in diabetic Ins2+/Akita mice.  (A) Ins2+/Akita AM fibers 
displayed a reduced rate of action potential discharge in response to 15s applications of 15g and 20g force, 
compared to wildtype fibers (p=0.008 for 15g, p=0.0012 for 20g, Mann-Whitney U-test). (B) Ins2+/Akita 
AM fibers display a reduced rate of firing in response to application of 20g force, with a particularly marked 
reduction during the first few seconds of the stimulus. (C) WT AM fibers attained significantly higher 
maximal firing rates in response to applications of both 15 and 20g (p=0.002 for 15g and p=0.005 for 20g, 
Mann-Whitney U-test) compared to diabetic AM fibers. (D) Example traces of Ins2+/Akita and wildtype AM 
fibers demonstrating the markedly reduced response rate in diabetic AM fibers. (E) Ins2+/Akita and wildtype 
AM fibers responses evoked by increasing force ramps. (F) The temporal pattern of impulse discharge rates 
evoked by 20g force ramps in Ins2+/Akita and wildtype AM fibers. * p<0.05; **p<0.01, compared to 
wildtype, Mann-Whitney U-test.  All fibers were recorded in preparations from 20 weeks old male mice.  
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Figure 4. C mechano-nociceptors are impaired in diabetic Ins2+/Akita mice.  The rate of action potential 
discharge evoked by 15s force steps (A), and the mean temporal discharge pattern produced by 20g steps 
(B) in Ins2+/Akita and wildtype CM fibers are shown. (C) Application of force ramp stimuli evoked a 
significantly reduced rate of impulse discharge in Ins2+/Akita compared to WT CM fibers at 20g, with a 
pattern of reduced response rates at lower ramp forces (p=0.035, Mann-Whitney U-test). (D) The mean 
firing patterns evoked by stimulation of Ins2+/Akita and WT CM fibers with 20g ramps, show that diabetic 
CM fibers respond with reduced discharge rates throughout the stimulus, particularly in response to the peak 
force at the end of the challenge. (E) Typical traces of the response of Ins2+/Akita and WT CM fibers 
illustrate that diabetic CM fibers produce fewer action potentials in response to application of 20g force 
ramps.  * p<0.05; **p<0.01, compared to wildtype, Mann-Whitney U-test. All fibers were recorded in 
preparations from 20 weeks old male mice.  
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Figure 5. Temperature evoked responses in C-mechano nociceptors. Distribution of temperature thresholds 
and the temperature change required to elicit cold (A and B) and heat activation (F and G) in Ins2+/Akita 
and wildtype C-mechano nociceptors is shown. The number of cold evoked action potentials was significantly 
reduced in CM nociceptors from Ins2+/Akita mice compared to wildtype mice as shown by the average 
response to a 60 second cold ramp (C) and their response pattern (D). An overall reduction in heat evoked 
action potentials from Ins2+/Akita mice was observed compared to wildtype mice (H and I), but the 
difference did not reach statistical significance. (E and J) Example traces of a wildtype and diabetic CM 
nociceptors responding to cold and heat, respectively is shown. *P<0.05, compared to wildtype, Mann-
Whitney U-test, the numbers of studied fibers in the different categories are indicated in panels D and I. All 
fibers were recorded in preparations from 20 weeks old male mice.  
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Figure 6.  Temperature evoked responses in DRG neurons. (A) DRG neurons loaded with Fura-2 were 
challenged with cold and heat followed by the TRPM8 agonist icilin (1 µM), the TRPV1 agonist capsaicin (1 
µM) and KCl (50 mM).  The black trace is an example of a typical icilin- and cold-senstive neuron.  This 
neuron exhibits an off-response after the heat ramp, when the temperature is returned to ~30 °C.  The grey 
trace is an example of a heat- and capsaicin-sensitive neuron.  (B) Neurons that responded to a 
temperature ramp with a discontinuous rate of [Ca2+]i-increase were considered heat/cold sensitive and 
included in the analysis.  Distribution of temperature thresholds for heat activation (C) and cold activation 
(E) in Ins2+/Akita and wildtype neurons.  (D) Heat evoked [Ca2+]i-response amplitudes were reduced in 
neurons from Ins2+/Akita mice compared to wildtype mice, whereas the amplitude of cold responses were 
unchanged (F). *P<0.05, ***P<0.001, unpaired t-test.  DRG neurons were isolated from male mice of 12 or 
20 weeks of age.  
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Figure 7.  Recovery from sensory neuropathy following islet transplantation.  (A) Intraepidermal nerve fibers 
(IENFs) were visualized by immunostaining for PGP9.5. The scalebar is 20µm. (B) The IENF density was 
significantly reduced in skin sections from male 20 weeks old Ins2+/Akita mice compared to age-matched 
wildtype littermates.  Male diabetic Ins2+/Akita mice were transplanted at an age of 14-20 
weeks.  Following islet transplantation (5-6 weeks), the IENF density recovered to the level seen in healthy 
wildtype mice.  (C) Blood glucose concentration was progressively restored following islet transplantation, 
reaching normoglycemic levels after 2-3 weeks.  (D) The sensitivity to noxious mechanical (paw-pressure 
test) and (E) cold (cold-plate) stimulation rapidly increased to wildtype level following islet transplantation 
(compare to wildtype in Fig. 1C, E).  Individual data points from each of n=5 transplanted mice are shown in 
C-E. The areas shaded in grey (C-E) indicate the level in male wildtype littermates (mean ± SD).  Data in B 
are the individual raw values and the box indicates median with interquartile range of n=5-7 mice. *P<0.05, 
**P<0.01, ***P<0.001, ANOVA followed by Tukey’s (compared to Ins2+/Akita panel B) or Dunnett’s 
(compared to pre-transplantation, panels C-E) post-hoc test.  
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